CClinicalTrials.gg
CompletedNCT03773757IN-PEACEUpdated Aug 27, 2024Results posted

Indiana Palliative Excellence in Alzheimer's Care Efforts

An interventional study of IN-PEACE Dementia Care Coordination in Dementia, sponsored by Indiana University. Completed at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-08-27.

Sponsored by Indiana University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
402
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

The overarching goal of this research is to improve the care of community dwelling patients with dementia and their family caregivers through an innovative model of supportive care that combines an existing, evidence-based intervention for dementia care with an innovative intervention for palliative care in dementia. The intervention projects this care into the homes of patients and caregivers, empowering caregivers, and integrating with ongoing care. IN-PEACE will enroll 200 patient-caregiver dyads, randomizing 100 dyads each to the intervention and usual care arms and follow for 24 months with quarterly outcome assessments. The core of the multi-component intervention is regular, proactive telephone contact by a dementia care coordinator (DCC; social worker or RN) to anticipate and identify patients' symptoms and caregivers needs and address by utilizing specific, evidence-based protocols. Protocols cover basic dementia care, caregiver distress, neuropsychiatric symptoms, pain, navigating the hospital, feeding difficulties, and transition to hospice. The intervention also involves advance care planning and support with caregivers tailored to decisions faced in dementia care, highlighting where palliative care options can replace the default that often results in burdensome treatments.

The primary aim of IN-PEACE is to test the effect of the intervention on patients' neuropsychiatric symptoms. Other aims include testing the effect of IN-PEACE on patients' overall symptom outcomes, caregiver mood and distress, and the provision of burdensome treatments to patients (hospitalizations and emergency room visits).

Read the detailed description

Dementia is an increasingly prevalent, costly and burdensome condition. The dramatic aging of the US population is creating a dementia "epidemic" that our health care system is poorly prepared to handle. More than 5 million people are affected by Alzheimer's disease (AD) and related dementias in 2016, with that number estimated to nearly triple to 13.8 million by 2050. The direct health care costs alone for dementia care are projected to increase from $236 billion in 2016 to more than $1 trillion in 2050. In addition to cognitive and functional deterioration, patients with dementia experience behavioral and psychological complications such as agitation and depression. Family caregivers of patients with dementia experience higher levels of anxiety, depression, chronic fatigue, and an increased mortality risk.

Dementia and palliative care are national research priorities. Both dementia and palliative care have been identified as priority conditions for research and quality improvement by numerous organizations such as the Institute of Medicine, National Quality Forum, the Centers for Medicare and Medicaid Services, and Agency for Healthcare Research and Quality and National Institute on Aging. In addition, a workgroup developing milestones for care and support under the U.S. National Alzheimer's Plan has explicitly stated that palliative care needs to be incorporated throughout the course of caring for patients and families affected by dementia.

2.0 Rationale and Specific Aims

Aim 1: To test the effect of the IN-PEACE intervention on patients' neuropsychiatric symptoms (e.g., agitation/aggression, anxiety, repetitive behaviors). Mixed effects models will be used to compare repeated Neuropsychiatric Inventory Questionnaire (NPI-Q) scores obtained at 3, 6, 9, 12, 15, 18, 21, and 24 months. Repeatedly measured NPI-Q scores will be the dependent variable in the model.

Aim 2: To test the effect of the IN-PEACE intervention on patients' overall symptom outcomes. Analyses in this aim will use repeatedly measured Symptom Measures in End-of-Life Dementia (SM-EOLD) scores over 24 months of follow-up as the dependent variable in the mixed effects model, similarly to the approach described for Aim 1.

Aim 3: To test the effect of the IN-PEACE intervention on caregivers' distress and mood. Aim 3 analyses will use repeatedly measured caregiver NPI-Q distress scores and caregiver Patient Health Questionnaire (PHQ-9) over 24 months of follow-up as the dependent variables in separate mixed effects models, similar to the approach for Aim 1.

Aim 4: Evaluate the effect of the IN-PEACE intervention on ER/hospital use. ER/hospitalization events will be obtained from accessing electronic medical records maintained by the Indiana Health Information Exchange (IHIE) and the Indiana Network for Patient Care (INPC). Poisson regression models will be used to compare rates of any ER/hospitalization event between the two groups while adjusting for dementia severity and significant baseline variables that differ between the two groups.

02

Conditions studied

  • Dementia

Browse trials for

03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's enrollment of 402 is above the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Indiana University is the lead sponsor of 958 studies on the registry; 200 are open to participants now.

Of its 142 completed or terminated interventional studies of FDA-regulated products, 112 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: Community-dwelling and living in the Indianapolis metropolitan area; Patient with an established diagnosis of dementia of any etiology; Dementia in the moderate (FAST stage 5) to severe stage (FAST 6-7); and English-speaking Primary caregiver informant enrolled in study.

Exclusion Criteria: Patient with dementia residing in a nursing facility or receiving hospice care; Patient or Caregiver with long-standing history of severe mental illness or Psychiatric disorder preexisting the dementia diagnosis. Initially, non-English speaking patients were excluded. On April 14, 2020, Institutional Review Board (IRB) Amendment eliminated this exclusion so non-English speaking patients could be enrolled as long as their Caregiver was English-speaking and able to complete assessments.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
402 participants (actual)

Study arms

  • Experimental
    IN-PEACE Dementia Care Coordination

    In-PEACE intervention arm will have monthly contact with a dementia care coordinator (DCC) to to identify symptoms the person with memory problems is having, including: pain, sadness, or other symptoms. The Dementia Care Coordinator will consult with the project clinical team to develop a plan of care utilizing standardized protocols to reduce the burdens of disease associated symptoms and behaviors.

    Behavioral: IN-PEACE Dementia Care Coordination

  • No intervention
    Usual Care

    The usual care arm will have access to education and informational materials from the local chapter of the Alzheimer's Association and other community resources and will be reminded of these resources throughout the study.

Interventions

  • BehavioralIN-PEACE Dementia Care Coordination

    Patient/Caregivers assigned to the intervention arm will have monthly phone calls with a Nurse or Social Worker, in the capacity of a Dementia care coordinator (DCC) to identify symptoms and behavior problems the person with memory problems is having, including: pain, sadness, or other symptoms. The Dementia Care Coordinator will consult with the project clinical team to develop a plan of care utilizing standardized protocols to reduce the burdens of disease associated symptoms and behaviors. In addition, education and support materials will be provided to the caregiver in the role caring and management of a patient with dementia.

06

What researchers measure

Primary outcomes

  1. Neuropsychiatric Inventory Questionnaire (NPI-Q) for Patient Symptom and Severity

    The Neuropsychiatric Inventory Questionnaire measures the presence and severity of 12 neuropsychiatric symptoms in the person with dementia (PWD) in the past month per caregiver report. Each symptom reported as present is scored on a scale of 1-3 with higher scores indicating more severity of the symptom: mild, moderate, or severe. The NPI-Q Patient Symptom and Severity total score is constructed by summing the value of each presenting symptom's severity and ranges from 0-36 with higher scores indicating more severe patient neuropsychiatric symptoms.

    Time frame: 0-24 months

Secondary outcomes

  1. Symptom Management - End of Life for Dementia (SM-EOLD)

    The Symptom Measures in End-of-Life Dementia (SM-EOLD) measures the presence and frequency of 9 symptoms experienced by the person with dementia (PWD) in the previous 90 days per caregiver report: pain, shortness of breath, depression, fear, anxiety, agitation, calm, skin breakdown, and resistance to care. Each symptom is scored on a scale ranging 0 - 5 (daily, several days a week, once a week, 2 or 3 days a month, once a month, never) with higher scores indicating better symptom control. The SM-EOLD total score is constructed by summing the value of each item, and ranges from 0-45 with higher scores indicating better symptom control (comfort).

    Time frame: 0-24 months

  2. Patient Health Questionnaire (PHQ-8) Caregiver

    The Patient Health Questionnaire-8 item measures the frequency of depressive symptoms experienced by the caregiver in the last two weeks per caregiver report. Each symptom is scored on a scale of 0-3 (not at all, several days, more than half the days, nearly every day) with higher scores indicating more frequency of depressive symptoms. The PHQ-8 Caregiver total score is constructed by summing the value of each item and ranges from 0-24 with higher scores indicating more frequent depressive symptoms in the caregiver.

    Time frame: 0-24 months

  3. Neuropsychiatric Inventory Questionnaire (NPI-Q) Caregiver Distress

    The Neuropsychiatric Inventory Questionnaire measures the presence and severity of 12 neuropsychiatric symptoms in the person with dementia (PWD) in the past month per caregiver report. If the symptom was reported as present, then the caregiver rated the level of distress they experienced related to the patient's symptom on a scale of 0-5 with higher scores indicating more distress. The NPI-Q Caregiver Distress total score is constructed by summing the value of each distress item and ranges from 0-60 with higher scores indicating more caregiver distress.

    Time frame: 0-24 months

  4. Emergency Department Visits and Hospitalizations

    Combined measure of counts of emergency department (ED) visits and hospital admissions drawn from hospital reported data in the Indiana Network for Patient Care (INPC) database, managed by the Indiana Health Information Exchange (IHIE). As pre-specified, this data only includes the patient from each dyad and not the caregiver.

    Time frame: 0-24 months

07

Results

Posted May 16, 2024
Limitations and caveats
Study subjects drawn primarily from two health systems in central Indiana and required to have an English-speaking caregiver. No technical difficulties; targeted enrollment completed on time and intervention and data collection very complete despite coronavirus disease 2019 (COVID-19) pandemic and move to fully remote operations. Low levels of symptoms in patients and caregivers in both arms may have limited ability to demonstrate impact of intervention on these measures.

Participant flow

Recruitment started on 3/14/2019 and ended on 12/21/2020. Recruitment locations included two health systems and personal referrals at a caregiver symposium within a 50-mile radius of Indianapolis. Initially, recruitment included an in-person approach in the medical clinic followed by in-person enrollment in the caregiver's home. After the Institutional Review Board (IRB) approved verbal consent 3/17/2020, all recruitment took place over the phone.

Participant flow — Overall Study
MilestoneIN-PEACE Dementia Care CoordinationUsual Care
Started198204
Completed196200
Not completed24
Withdrew: Withdrawal by subject24

Outcome measures

PrimaryNeuropsychiatric Inventory Questionnaire (NPI-Q) for Patient Symptom and Severity

The Neuropsychiatric Inventory Questionnaire measures the presence and severity of 12 neuropsychiatric symptoms in the person with dementia (PWD) in the past month per caregiver report. Each symptom reported as present is scored on a scale of 1-3 with higher scores indicating more severity of the symptom: mild, moderate, or severe. The NPI-Q Patient Symptom and Severity total score is constructed by summing the value of each presenting symptom's severity and ranges from 0-36 with higher scores indicating more severe patient neuropsychiatric symptoms.

Time frame:
0-24 months
Reported as:
Mean · score on a scale
Neuropsychiatric Inventory Questionnaire (NPI-Q) for Patient Symptom and Severity
score on a scaleIN-PEACE Dementia Care CoordinationUsual Care
Neuropsychiatric Inventory Questionnaire (NPI-Q) for Patient Symptom and Severity9.149 ± 0.7479.39 ± 0.756
Statistical analysis
  • IN-PEACE Dementia Care Coordination vs Usual Care · Mixed Models Analysis · p = 0.8719
SecondarySymptom Management - End of Life for Dementia (SM-EOLD)

The Symptom Measures in End-of-Life Dementia (SM-EOLD) measures the presence and frequency of 9 symptoms experienced by the person with dementia (PWD) in the previous 90 days per caregiver report: pain, shortness of breath, depression, fear, anxiety, agitation, calm, skin breakdown, and resistance to care. Each symptom is scored on a scale ranging 0 - 5 (daily, several days a week, once a week, 2 or 3 days a month, once a month, never) with higher scores indicating better symptom control. The SM-EOLD total score is constructed by summing the value of each item, and ranges from 0-45 with higher scores indicating better symptom control (comfort).

Time frame:
0-24 months
Reported as:
Mean · score on a scale
Symptom Management - End of Life for Dementia (SM-EOLD)
score on a scaleIN-PEACE Dementia Care CoordinationUsual Care
Symptom Management - End of Life for Dementia (SM-EOLD)28.36 ± 0.97226.133 ± 0.984
Statistical analysis
  • IN-PEACE Dementia Care Coordination vs Usual Care · Mixed Models Analysis · p = 0.8389
SecondaryPatient Health Questionnaire (PHQ-8) Caregiver

The Patient Health Questionnaire-8 item measures the frequency of depressive symptoms experienced by the caregiver in the last two weeks per caregiver report. Each symptom is scored on a scale of 0-3 (not at all, several days, more than half the days, nearly every day) with higher scores indicating more frequency of depressive symptoms. The PHQ-8 Caregiver total score is constructed by summing the value of each item and ranges from 0-24 with higher scores indicating more frequent depressive symptoms in the caregiver.

Time frame:
0-24 months
Reported as:
Mean · score on a scale
Patient Health Questionnaire (PHQ-8) Caregiver
score on a scaleIN-PEACE Dementia Care CoordinationUsual Care
Patient Health Questionnaire (PHQ-8) Caregiver4.472 ± 0.5074.522 ± 0.511
Statistical analysis
  • IN-PEACE Dementia Care Coordination vs Usual Care · Mixed Models Analysis · p = 0.3431
SecondaryNeuropsychiatric Inventory Questionnaire (NPI-Q) Caregiver Distress

The Neuropsychiatric Inventory Questionnaire measures the presence and severity of 12 neuropsychiatric symptoms in the person with dementia (PWD) in the past month per caregiver report. If the symptom was reported as present, then the caregiver rated the level of distress they experienced related to the patient's symptom on a scale of 0-5 with higher scores indicating more distress. The NPI-Q Caregiver Distress total score is constructed by summing the value of each distress item and ranges from 0-60 with higher scores indicating more caregiver distress.

Time frame:
0-24 months
Reported as:
Mean · score on a scale
Neuropsychiatric Inventory Questionnaire (NPI-Q) Caregiver Distress
score on a scaleIN-PEACE Dementia Care CoordinationUsual Care
Neuropsychiatric Inventory Questionnaire (NPI-Q) Caregiver Distress9.282 ± 1.06310.148 ± 1.073
Statistical analysis
  • IN-PEACE Dementia Care Coordination vs Usual Care · Mixed Models Analysis · p = 0.6612
SecondaryEmergency Department Visits and Hospitalizations

Combined measure of counts of emergency department (ED) visits and hospital admissions drawn from hospital reported data in the Indiana Network for Patient Care (INPC) database, managed by the Indiana Health Information Exchange (IHIE). As pre-specified, this data only includes the patient from each dyad and not the caregiver.

Time frame:
0-24 months
Reported as:
Count of participants · Participants
Emergency Department Visits and Hospitalizations
ParticipantsIN-PEACE Dementia Care CoordinationUsual Care
Emergency Department Visits and Hospitalizations5080
Statistical analysis
  • IN-PEACE Dementia Care Coordination vs Usual Care · Zero-Inflated Poisson Regression Model · p = 0.0007

Adverse events

Collected over Through study completion, up to 24 months or the death of the patient. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
IN-PEACE Dementia Care Coordination40/99 (40.4%)50/99 (50.5%)77/99 (77.8%)
Usual Care43/102 (42.2%)61/102 (59.8%)89/102 (87.3%)
Most frequent serious events
Most frequent serious events
EventIN-PEACE Dementia Care CoordinationUsual Care
HospitalizationsGeneral disorders50/9961/102
Most frequent other events
Most frequent other events
EventIN-PEACE Dementia Care CoordinationUsual Care
ED VisitsGeneral disorders60/9981/102
FallsNervous system disorders35/9942/102
ElopementsNervous system disorders26/9915/102
Other AccidentsGeneral disorders8/997/102

Baseline characteristics

These variables were collected for all participant dyads (patient plus caregiver) randomized to either the usual care arm or dementia care coordination arm. Some variables may not total overall participants if caregiver opted not to answer that item.

Age, Continuous
Age, Continuous(years)IN-PEACE Dementia Care CoordinationUsual CareTotal
Patient Participants83.7 ± 7.783.4 ± 8.183.6 ± 7.9
Caregiver Participants60.8 ± 12.360.2 ± 10.160.5 ± 11.2
Sex: Female, Male
Sex: Female, Male(Participants)IN-PEACE Dementia Care CoordinationUsual CareTotal
Patient Participants — Female6769136
Patient Participants — Male323365
Caregiver Participants — Female8281163
Caregiver Participants — Male172138
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)IN-PEACE Dementia Care CoordinationUsual CareTotal
Patient Participants — Hispanic or Latino235
Patient Participants — Not Hispanic or Latino9495189
Patient Participants — Unknown or Not Reported347
Caregiver Participants — Hispanic or Latino235
Caregiver Participants — Not Hispanic or Latino9494188
Caregiver Participants — Unknown or Not Reported358
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)IN-PEACE Dementia Care CoordinationUsual CareTotal
African American: PWD444387
African American: Caregiver434689
White: PWD4853101
White: Caregiver4952101
Others: PWD347
Others: Caregiver325
Refused to Answer: PWD426
Refused to Answer: Caregiver426
Region of Enrollment
Region of Enrollment(Dyad: Patient and Caregiver)IN-PEACE Dementia Care CoordinationUsual CareTotal
United States99102201
Education
Education(Participants)IN-PEACE Dementia Care CoordinationUsual CareTotal
PWD — High School or Less5353106
PWD — Some college or college degree302959
PWD — Post graduate161935
PWD — did not answer011
Caregiver — High School or Less131831
Caregiver — Some college or college degree6054114
Caregiver — Post graduate262955
Caregiver — did not answer011
Marital Status
Marital Status(Participants)IN-PEACE Dementia Care CoordinationUsual CareTotal
PWD — Divorced/Separated251237
PWD — Married/Living together323062
PWD — Never Married6814
PWD — Widowed365288
Caregiver — Divorced/Separated131528
Caregiver — Married/Living together6671137
Caregiver — Never Married191332
Caregiver — Widowed134
Income
Income(Participants)IN-PEACE Dementia Care CoordinationUsual CareTotal
PWD : Under $24,999 — Yes463783
PWD : Under $24,999 — No5365118
PWD : $25,000 - 49,999 — Yes122133
PWD : $25,000 - 49,999 — No8781168
PWD : $50,000 - 99,999 — Yes6713
PWD : $50,000 - 99,999 — No9395188
PWD : $100,000 and over — Yes358
PWD : $100,000 and over — No9697193
PWD : Do not wish to answer — Yes101424
PWD : Do not wish to answer — No8988177
PWD : Caregiver is the spouse — Yes201838
PWD : Caregiver is the spouse — No7984163
Caregiver : Under $24,999 — Yes131326
Caregiver : Under $24,999 — No8689175
Caregiver : $25,000 - 49,999 — Yes262955
Caregiver : $25,000 - 49,999 — No7373146
Caregiver : $50,000 - 99,999 — Yes232144
Caregiver : $50,000 - 99,999 — No7681157
Caregiver : $100,000 and over — Yes242953
Caregiver : $100,000 and over — No7573148
Caregiver : Do not wish to answer — Yes131023
Caregiver : Do not wish to answer — No8692178

11 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Sandra Eskenazi Center for Brain Care Innovation
    Indianapolis, Indiana 46202, United States
09

References and documents

Publications

  • Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):233-9. doi: 10.1176/jnp.12.2.233. PubMed 11001602 ↗
  • Volicer L, Hurley AC, Blasi ZV. Scales for evaluation of End-of-Life Care in Dementia. Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):194-200. doi: 10.1097/00002093-200110000-00005. PubMed 11723370 ↗
  • Lowe B, Unutzer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004 Dec;42(12):1194-201. doi: 10.1097/00005650-200412000-00006. PubMed 15550799 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 10, 2020
  • Informed consent form · Mar 29, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03773757
Lead sponsor
Indiana University
Collaborators
Regenstrief Institute, Inc., National Institute on Aging (NIA)
Responsible party
Greg Sachs (Professor of Medicine, Division Chief General Internal Medicine and Geriatrics, Indiana University) — Principal investigator
First posted
Dec 12, 2018
Start date
Mar 14, 2019
Primary completion
Jan 7, 2023
Completion
Jan 7, 2023
Results posted
May 16, 2024
Last update
Aug 27, 2024

Study contacts

Greg A Sachs, MD
principal investigator · Indiana University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion